A new study published in JCO Clinical Cancer Informatics tackles a critical challenge in cancer diagnostics: ensuring that artificial intelligence (AI) performs equitably across racially diverse patient populations. This research marks a milestone in prostate cancer care, presenting the first large-scale comparative analysis of a digital pathology AI prognostic model in both African American and non–African American patients. The findings offer key insights into the performance of AI in addressing bias in oncologic outcomes.
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now